Skip to main content
Seth Field, MD, Endocrinology, Cleveland, OH

Seth Joel Field MD PhD

Diabetes, Lipid Metabolism


Professor of Medicine/Endocrinology, Case Western Reserve University Investigator, Harrington Discovery Institute, University Hospitals Cleveland Medical Center

Join to View Full Profile
  • UH Cleveland Medical Center11100 Euclid Ave Department of Medicine-EndocrinologyCleveland, OH 44106

  • Phone+1 216-844-8500

  • Fax+1 216-844-3120

Dr. Field is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

Education & Training

  • Mass General Brigham/Massachusetts General Hospital
    Mass General Brigham/Massachusetts General HospitalFellowship, Endocrinology, Diabetes, and Metabolism, 1999 - 2002
  • University of Pennsylvania Health System
    University of Pennsylvania Health SystemResidency, Internal Medicine, 1997 - 1999
  • Harvard Medical School
    Harvard Medical SchoolClass of 1997

Certifications & Licensure

  • CA State Medical License
    CA State Medical License 2005 - 2026
  • OH State Medical License
    OH State Medical License 2020 - 2026
  • MA State Medical License
    MA State Medical License 1999 - 2005
  • PA State Medical License
    PA State Medical License 1998 - 1999
  • Endocrinology, Diabetes and Metabolism
    American Board of Internal Medicine Endocrinology, Diabetes and Metabolism

Awards, Honors, & Recognition

  • Elected Member The American Society for Clinical Investigation, 2011

Publications & Presentations

PubMed

Grant Support

  • Mechanism of Action of a Novel Golgi-Targeted Anti-Cancer AgentCASE WESTERN RESERVE UNIVERSITY2020–2025
  • Targeting A Novel Phosphoinositide Signaling Pathway For Cancer TherapyNational Cancer Institute2009–2010
  • Phosphoinositides Provide Unique Insights Into Cell Biology And PathophysiologyOffice Of The Director, National Institutes Of Health2008
  • Pi-3-Kinase Signaling Over Physiologic Time-Scales/Response To Insulin Or IGF-1National Institute Of Diabetes And Digestive And Kidney Diseases2006–2007
  • Pi-3-Kinase Mediated Signaling By Insulin And IGF-1National Institute Of Diabetes And Digestive And Kidney Diseases2004–2007
  • Pi-3-Kinase Mediated Signaling By Insulin And IGF-1National Institute Of Diabetes And Digestive And Kidney Diseases2003–2004

Viewing the full profile is available to verified healthcare professionals only.

Find your profile and take control of your online presence: